معرفی
Dr. Kimberly Perez is an Assistant Professor of Medicine at Harvard Medical School and a Clinical Investigator at the Hale Family Center for Pancreatic Cancer Research. She serves as a Senior Physician in Medical Oncology at the Dana-Farber Cancer Institute and an Associate Physician at Brigham and Women’s Hospital. Dr. Perez co-directs the DFCI Gastrointestinal Clinical Trials program and is actively involved in both patient care and clinical research focused on gastrointestinal cancers and inherited cancer syndromes.
Research Interests: Dr. Perez specializes in gastrointestinal oncology, with a strong focus on pancreatic adenocarcinoma and neuroendocrine tumors. Her work integrates clinical trials with translational research to develop novel therapies. She leads multi-institutional trials and contributes to national therapeutic guidelines. Her research spans hereditary cancer syndromes, precision oncology, and the genomic characterization of advanced cancers.
The recent publications highlight her leadership in clinical and translational research in pancreatic cancer, emphasizing genomic profiling, perioperative strategies, and novel drug combinations. Her work increasingly integrates germline genetics, somatic mutation analysis, and real-time genomic characterization to advance precision medicine.
Scientific Awards:
Advising and Grants: While formal advisees are not listed, Dr. Perez leads and collaborates on multiple investigator-initiated and multi-institutional clinical trials. She has been instrumental in securing research support through institutional and collaborative grants, particularly within the Hale Family Center for Pancreatic Cancer Research. Her role as co-Director of the GI Clinical Trials program underscores her leadership in trial design and execution.
Labs and Teams: Dr. Perez is a key member of the Dana-Farber Cancer Institute/Harvard Cancer Center Gastrointestinal Oncology and Cancer Genetics and Prevention disease centers. She works closely with interdisciplinary teams including molecular biologists, geneticists, surgeons, and data scientists to advance pancreatic cancer research and treatment.
